Oscar Health (OSCR) Cash from Financing Activities (2020 - 2026)

Oscar Health's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$3.6 million for Q1 2026.

• Quarterly Cash from Financing Activities fell 173.88% year-over-year to -$3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $390.7 million (up 750.32% YoY) and the FY2025 annual result came in at $399.2 million, up 483.74% from the prior year.
• Cash from Financing Activities was -$3.6 million for Q1 2026 at Oscar Health, down from $8.2 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $364.0 million in Q3 2025 and bottomed at -$3.6 million in Q1 2026.
• A 5-year average of $45.4 million and a median of $3.8 million in 2024 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 5297.04% — and 2026, when it tumbled 173.88%.
• Oscar Health's Cash from Financing Activities stood at $527000.0 in 2022, then jumped by 102.85% to $1.1 million in 2023, then jumped by 257.06% to $3.8 million in 2024, then surged by 114.07% to $8.2 million in 2025, then slumped by 144.06% to -$3.6 million in 2026.
• Business Quant data shows OSCR's Cash from Financing Activities at -$3.6 million in Q1 2026, $8.2 million in Q4 2025, and $364.0 million in Q3 2025.